Drug intelligence / Profile preview

amino acids + glucose

Development stage
Unknown
Lead developer
Erasmus MC
Modality
Small Molecules
Administration
Intravenous, Parenteral
01

Overview

Amino acid + glucose intradialytic parenteral nutrition (IDPN) is a specialized intravenous nutritional support therapy administered to patients with end-stage kidney disease (ESKD) during their hemodialysis sessions. This intervention is designed to combat protein-energy wasting (PEW) and muscle protein turnover abnormalities, which are common complications in chronic dialysis patients due to the catabolic nature of the procedure and often inadequate oral intake. The formulation typically consists of a concentrated mixture of essential and non-essential amino acids along with glucose (dextrose), providing both the building blocks for protein synthesis and an energy source to spare protein from oxidation. By delivering these nutrients directly into the venous drip chamber of the dialysis circuit, IDPN bypasses the gastrointestinal tract and counteracts the nutrient losses that occur during dialysis. The LOTUS trial, conducted by Erasmus MC, specifically evaluates the efficacy of this nutritional strategy in improving muscle protein synthesis and amino acid balance in chronic hemodialysis patients.

Other names
IDPNintradialytic parenteral nutritionamino acid and glucose intradialytic parenteral nutrition
02

Targets

Amino acid nutrient sensors upstream of mTORC1

Beyond the preview

Go deeper on amino acids + glucose.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on amino acids + glucose.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call